OEL Fastrac Catalog

Please note, this OEL/ADE monograph also applies to choline chloride (CAS RN 67-48-1), choline bitartrate (CAS RN 87-67-2), choline citrate (CAS RN 77-91-8), choline hydroxide (CAS RN 123-41-1), choline bicarbonate (CAS RN 78-73-9), choline sulfate (CAS RN 4858-96-2), and choline hydrogen sulfate (CAS RN 16655-25-7). Additionally, this monograph contains the pediatric ADE (pADE). Choline is a naturally occurring compound that is necessary for human health. Choline is manufactured in the body and occurs in a wide range of foods from plants and animals. Foods are supplemented with choline to maintain adequate nutritional intake and as a flavor enhancer. The salt forms of choline (choline chloride and choline bitartrate) are added to many infant formulas. Choline accelerates synthesis and release of acetylcholine, a neurotransmitter necessary for normal muscle control, memory and other functions. It is a precursor of phospholipids that are required in cell membranes, intracellular signaling and removal of cholesterol from the liver.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Please note: Due to the complexity and amount of studies regarding this compound—a Natural Health Product—increased cost is charged.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Choline, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.